ROIV
Price
$10.15
Change
+$0.13 (+1.30%)
Updated
Apr 17 closing price
Capitalization
7.24B
68 days until earnings call
VERA
Price
$21.29
Change
+$0.05 (+0.24%)
Updated
Apr 17 closing price
Capitalization
1.36B
19 days until earnings call
Ad is loading...

ROIV vs VERA

Header iconROIV vs VERA Comparison
Open Charts ROIV vs VERABanner chart's image
Roivant Sciences
Price$10.15
Change+$0.13 (+1.30%)
Volume$2.63M
Capitalization7.24B
Vera Therapeutics
Price$21.29
Change+$0.05 (+0.24%)
Volume$661.24K
Capitalization1.36B
ROIV vs VERA Comparison Chart
Loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROIV vs. VERA commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a Hold and VERA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (ROIV: $10.15 vs. VERA: $21.29)
Brand notoriety: ROIV and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROIV: 39% vs. VERA: 64%
Market capitalization -- ROIV: $7.24B vs. VERA: $1.36B
ROIV [@Biotechnology] is valued at $7.24B. VERA’s [@Biotechnology] market capitalization is $1.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROIV’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • ROIV’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROIV’s TA Score shows that 5 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • ROIV’s TA Score: 5 bullish, 4 bearish.
  • VERA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VERA is a better buy in the short-term than ROIV.

Price Growth

ROIV (@Biotechnology) experienced а +5.18% price change this week, while VERA (@Biotechnology) price change was -2.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

ROIV is expected to report earnings on Aug 18, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.24B) has a higher market cap than VERA($1.36B). ROIV YTD gains are higher at: -14.201 vs. VERA (-49.657). ROIV has higher annual earnings (EBITDA): 4.1B vs. VERA (-144.42M). ROIV has more cash in the bank: 5.15B vs. VERA (641M). VERA has less debt than ROIV: VERA (54.6M) vs ROIV (100M). ROIV has higher revenues than VERA: ROIV (123M) vs VERA (0).
ROIVVERAROIV / VERA
Capitalization7.24B1.36B533%
EBITDA4.1B-144.42M-2,836%
Gain YTD-14.201-49.65729%
P/E Ratio1.97N/A-
Revenue123M0-
Total Cash5.15B641M803%
Total Debt100M54.6M183%
TECHNICAL ANALYSIS
Technical Analysis
ROIVVERA
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 5 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 22 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MVGIX17.040.14
+0.83%
MFS Low Volatility Global Equity I
TWDAX15.51N/A
N/A
Templeton World Adv
JVMSX24.50N/A
N/A
JHancock Disciplined Value Mid Cap R2
HRLSX8.73N/A
N/A
Hartford Real Asset R4
JUSYX14.87N/A
N/A
JPMorgan US Small Company R5

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.30%
IMVT - ROIV
59%
Loosely correlated
+2.09%
ACLX - ROIV
54%
Loosely correlated
+2.19%
RCKT - ROIV
50%
Loosely correlated
+2.93%
DYN - ROIV
49%
Loosely correlated
+4.34%
KYMR - ROIV
49%
Loosely correlated
+3.80%
More